Exploratory analysis of the TREAT EARLIER trial: is the efficacy of temporary methotrexate treatment dose-dependent?

Doortje I. Krijbolder; Hido D. Boom; Annette H.M. van der Helm-van Mil

doi:10.1016/S2665-9913(23)00164-9

Exploratory analysis of the TREAT EARLIER trial: is the efficacy of temporary methotrexate treatment dose-dependent?

Doortje I. Krijbolder^*, Hido D. Boom, Annette H.M. van der Helm-van Mil

^*Corresponding author for this work

Rheumatology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	e437-e439
Journal	The Lancet Rheumatology
Volume	5
Issue number	8
DOIs	https://doi.org/10.1016/S2665-9913(23)00164-9
Publication status	Published - Aug 2023

Bibliographical note

This work was supported by a ZonMW grant (programma translationeel onderzoek), by the European Research Council under the EU’s Horizon 2020 research and innovation programme (Starting grant, agreement No 714312), and the Dutch Arthritis Society. The funder had no role in analysis and interpretation of the data, or writing of the manuscript.

Access to Document

10.1016/S2665-9913(23)00164-9

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615883

Cite this

@article{47062580b6714bddb6c793e09e58ab3e,

title = "Exploratory analysis of the TREAT EARLIER trial: is the efficacy of temporary methotrexate treatment dose-dependent?",

author = "Krijbolder, {Doortje I.} and Boom, {Hido D.} and {van der Helm-van Mil}, {Annette H.M.}",

note = "This work was supported by a ZonMW grant (programma translationeel onderzoek), by the European Research Council under the EU{\textquoteright}s Horizon 2020 research and innovation programme (Starting grant, agreement No 714312), and the Dutch Arthritis Society. The funder had no role in analysis and interpretation of the data, or writing of the manuscript.",

year = "2023",

month = aug,

doi = "10.1016/S2665-9913(23)00164-9",

language = "English",

volume = "5",

pages = "e437--e439",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier Ltd.",

number = "8",

}

TY - JOUR

T1 - Exploratory analysis of the TREAT EARLIER trial

T2 - is the efficacy of temporary methotrexate treatment dose-dependent?

AU - Krijbolder, Doortje I.

AU - Boom, Hido D.

AU - van der Helm-van Mil, Annette H.M.

N1 - This work was supported by a ZonMW grant (programma translationeel onderzoek), by the European Research Council under the EU’s Horizon 2020 research and innovation programme (Starting grant, agreement No 714312), and the Dutch Arthritis Society. The funder had no role in analysis and interpretation of the data, or writing of the manuscript.

PY - 2023/8

Y1 - 2023/8

UR - http://www.scopus.com/inward/record.url?scp=85165638850&partnerID=8YFLogxK

U2 - 10.1016/S2665-9913(23)00164-9

DO - 10.1016/S2665-9913(23)00164-9

M3 - Comment/Letter to the editor

C2 - 38251573

AN - SCOPUS:85165638850

SN - 2665-9913

VL - 5

SP - e437-e439

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 8

ER -

Exploratory analysis of the TREAT EARLIER trial: is the efficacy of temporary methotrexate treatment dose-dependent?

Bibliographical note

Access to Document

Other files and links

Cite this